logo
Plus   Neg
Share
Email

EARNINGS SUMMARY: Details of Protalix BioTherapeutics Inc. Q2 Earnings Report

Below are the earnings highlights for Protalix BioTherapeutics Inc. (PLX):

-Earnings: -$4.15 million in Q2 vs. -$7.74 million in the same period last year.
-EPS: -$0.13 in Q2 vs. -$0.52 in the same period last year.
-Analysts projected -$0.20 per share
-Revenue: $10.97 million in Q2 vs. $12.25 million in the same period last year.

For comments and feedback contact: editorial@rttnews.com

RELATED NEWS
Follow RTT